×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IMNM – immunome, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IMNM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/4
08:28 pm
imnm
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More [Globe and Mail, The (Toronto, Canada)]
Low
Report
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More [Globe and Mail, The (Toronto, Canada)]
4/4
07:36 pm
imnm
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More [Yahoo! Finance]
Low
Report
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More [Yahoo! Finance]
4/2
04:00 pm
imnm
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/11
12:55 am
imnm
Immunome: Upcoming NDA, Valuation, And Investment Case [Seeking Alpha]
Low
Report
Immunome: Upcoming NDA, Valuation, And Investment Case [Seeking Alpha]
3/7
02:59 am
imnm
Immunome (IMNM) was downgraded by Wall Street Zen from "hold" to "sel
Low
Report
Immunome (IMNM) was downgraded by Wall Street Zen from "hold" to "sel
3/6
05:29 pm
imnm
Did Reduced 2025 Losses and NDA Plans Just Shift Immunome's (IMNM) Investment Narrative? [Yahoo! Finance]
Low
Report
Did Reduced 2025 Losses and NDA Plans Just Shift Immunome's (IMNM) Investment Narrative? [Yahoo! Finance]
3/5
04:00 pm
imnm
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/4
01:10 pm
imnm
Immunome (IMNM) had its price target raised by Craig Hallum from $33.00 to $36.00. They now have a "buy" rating on the stock.
Low
Report
Immunome (IMNM) had its price target raised by Craig Hallum from $33.00 to $36.00. They now have a "buy" rating on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/3
07:48 pm
imnm
Form 4 Immunome Inc. For: Apr 02 Filed by: Higgins Jack
Low
Report
Form 4 Immunome Inc. For: Apr 02 Filed by: Higgins Jack
4/3
07:47 pm
imnm
Form 4 Immunome Inc. For: Apr 02 Filed by: Rosett Max
Low
Report
Form 4 Immunome Inc. For: Apr 02 Filed by: Rosett Max
4/3
09:49 am
imnm
Form 144/A Immunome Inc. Filed by: Rosett Max
Low
Report
Form 144/A Immunome Inc. Filed by: Rosett Max
4/2
11:47 am
imnm
Form 144 Immunome Inc. Filed by: Rosett Max
Low
Report
Form 144 Immunome Inc. Filed by: Rosett Max
4/2
11:32 am
imnm
Form 144 Immunome Inc. Filed by: Higgins Jack
Low
Report
Form 144 Immunome Inc. Filed by: Higgins Jack
4/1
05:39 pm
imnm
Form 4 Immunome Inc. For: Mar 30 Filed by: Higgins Jack
Low
Report
Form 4 Immunome Inc. For: Mar 30 Filed by: Higgins Jack
3/31
07:11 am
imnm
Form 4 Immunome Inc. For: Mar 27 Filed by: SIEGALL CLAY B
Medium
Report
Form 4 Immunome Inc. For: Mar 27 Filed by: SIEGALL CLAY B
3/26
11:43 am
imnm
Form SCHEDULE 13G/A Immunome Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Immunome Inc. Filed by: VANGUARD GROUP INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: